More than 12,000 bottles of blood plasma meant for health treatments that were produced by a Chinese pharmaceutical company have tested positive for HIV antibodies, causing an uproar among the Chinese public.
The batch of immunoglobulin for intravenous use was produced by the state-owned Shanghai Xinxing Medicine Co.
